This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Clinical Observation

J. B. FELDMAN, M.D.

Arch Ophthal. 1949;41(1):42-59.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE PURPOSE of this paper is to evaluate the clinical merit of the commonly available mydriatics as to such factors as safety, speed of action and return to normal pupillary size.

All drugs used in medicine have a range of dosage depending in part on the age of the patient and on whether the clinician desires the minimal or maximal effective dose for the patient in question. The same is true of drugs used in ocular diseases except that in ophthalmology particular care should be exercised when mydriatics are used. The initial evidences of overdosage of any drug are not usually disastrous, and the discontinuation of the drug ordinarily leads to complete return to normal in a short time. This tendency does not prevail with mydriatics. The use of a mydriatic in a patient with "potential glaucoma" may terminate in a serious complication, with a blind eye as a result. . . . [Full Text PDF of this Article]

Author Affiliations
PHILADELPHIA

From the Eye Clinics of the Hospital of the Protestant Episcopal Church and St. Christopher's Hospital for Children.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?